Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Columnists


Search by Name:

About Marc Davis

Marc Davis
Marc Davis, www.Capitalmarketsmedia.ca
Former floor trader, investment industry research analyst, journalist & CBC TV business reporter, Marc is steeped in news media & capital markets test test test test test test test.


Marc Davis's Most Recent Articles

Canagold: Sweet Surprise as a High-Grade Low-Cost Gold Deposit Delivers

It’s a big shot in the arm that promises to redouble the considerable scarcity value of the New...

Marc Davis | September 22, 2021

XPhyto: Buyouts, Biosensors and a Booming Business

Test, test, test! It’s the World Health Organization’s battle cry in the global war against COVID...

Marc Davis | August 4, 2021

Kodiak Copper: Why Scarcity and Size Matter Most

Location, location, location! So goes the time-honoured adage about the three golden rules of...

Marc Davis | July 7, 2021

NervGen Pharma: A “Blockbuster Drug” in the Making?

It has the potential to be one of the most disruptive pharmaceutical drug therapies of the modern...

Marc Davis | June 28, 2021

XPhyto: Proof of Concept for Mescalin Synthesis

It’s become a much talked-about story on both sides of the Atlantic. XPhyto Therapeutics Corp....

Marc Davis | June 10, 2021

XPhyto Therapeutics: Are they Selling the Solution to Germany’s Rapid Testing Crisis?

The Germans call it COVID-19 “rapid testing mania”. But like most manias, it has opened up a...

Marc Davis | June 3, 2021

Arctic Star: My Next HOME RUN?

Can I hit the ball out of the park once again? More specifically, can I identify a hidden gem...

Marc Davis | May 20, 2021

A Life Sciences Project Accelerator Kicks into High Gear

XPhyto Therapeutics Corp. (CSE: XPHY) (FSE: 4XT) (OTC: XPHYF) has been a hot story lately...

Marc Davis | May 11, 2021

Why the US is Backing American Lithium

It’s a strategically symbolic investment that clearly demonstrates the US government’s...

Marc Davis | April 30, 2021

Sierra Madre Gold & Silver: Mining’s Next Star Performer?

As the US economy bounces back, confident and emboldened investors are rushing back into...

Marc Davis | April 28, 2021
1 2 3 4 5 6 7 8 9 10 ... Next

Featured Company